Although MTD chemotherapy can inhibit tumor growth, MTD chemotherapy is generally believed to impair the immune system, including lymphopenia, myelosuppression, severe weight loss, and a reduction in CD8+ T cells 32. The gene discussed is CD8A; the disease is neoplasm.